U.S. Markets closed
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • Dow 30

    35,870.95
    -60.10 (-0.17%)
     
  • Nasdaq

    15,993.71
    +72.14 (+0.45%)
     
  • Russell 2000

    2,363.59
    -13.42 (-0.56%)
     
  • Gold

    1,861.20
    -0.20 (-0.01%)
     
  • Silver

    24.88
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1369
    -0.0006 (-0.0568%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • Vix

    17.59
    +0.48 (+2.81%)
     
  • GBP/USD

    1.3497
    -0.0003 (-0.0216%)
     
  • USD/JPY

    114.3040
    +0.0520 (+0.0455%)
     
  • BTC-USD

    54,030.80
    -4,709.68 (-8.02%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • FTSE 100

    7,255.96
    -35.24 (-0.48%)
     
  • Nikkei 225

    29,683.09
    +84.43 (+0.29%)
     

Company News for Sep 30, 2021

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Cintas Corporation’s CTAS shares rose 0.8% after the company reported first-quarter of fiscal 2022 earnings of $3.11 per share, surpassing the Zacks Consensus Estimate of $2.76.

  • Shares of NuCana plc NCNA surged 17.3% after the company reported that the FDA granted Fast Track designation to its Acelarin (NUC-1031) for the first-line treatment of patients with advanced biliary tract cancer.

  • GeoVax Labs, Inc.’s GOVX shares jumped 8.7% after the company reported the purchase of exclusive rights to PNP Therapeutics' development and commercialization of Gedeptin.

  • Shares of Lucid Group, Inc. LCID surged 7.1% after it kicked off production of its electric vehicles in Casa Grande, Arizona and reported that deliveries would begin in late October.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cintas Corporation (CTAS) : Free Stock Analysis Report
 
GeoVax Labs Inc. (GOVX): Free Stock Analysis Report
 
NuCana PLC Sponsored ADR (NCNA) : Free Stock Analysis Report
 
Lucid Group, Inc. (LCID) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.